Pharma Stocks
Pharma stocks to buy ahead of Q2 results: Acutaas Chemicals, Mankind Pharma, Ipca Labs - Max upside? Target price
Pharma results may benefit from rupee depreciation, particularly for exporters, though elevated freight and input costs remain risks. InCred sees potential pressure at Dr Reddy’s, Divi’s, Lupin, Cipla, Torrent Pharma and Blue Jet Healthcare in Q2FY27. Check its top stock picks in the segment.
2 min read8 Oct 2026With 300% rally in 5 years, multibagger stock in focus on Monday | Here's why - Details from exchange filing
The pharma stock closed 1% higher on Friday, ending the session at ₹39.42 apiece. The market capitalisation of Sudarshan Pharma stood at ₹984.16 crore, as of 4 September.
2 min read6 Sep 2026Cupid makes additional $5 million investment in GII Healthcare platform
Cupid has invested an additional $5 million in GII Healthcare Investment Limited, reinforcing its belief in the healthcare sector's growth. The investment, made entirely from internal funds, enhances Cupid's commitment to GII's long-term strategy without disclosing its stake size.
2 min read29 Jul 2026Trump's tariff policy: Abbott India, Ajanta Pharma to Alembic — pharma stocks crash up to 4%
Pharma stocks dipped on July 24 after President Trump announced a phased tariff plan for imported generic medicines, raising concerns for Indian exporters. Abbott India led losses at 3.69%, prompting fears over the future of American production and long-term impacts on stocks.
4 min read24 Jul 2026Cipla, Ajanta Pharma to Alkem Laboratories: Pharma stocks rise amid weak trends on Dalal Street
Torrent Pharmaceuticals and Mankind Pharma were the top gainers on the Nifty Pharma index with more than 3% rally each. Cipla, Divi’s Laboratories, Laurus Labs, Alkem Laboratories and Sai Life Sciences shares rose over 2% each.
2 min read20 Jul 2026Nifty Pharma jumps 14% YTD, outshines Nifty 50; is there more upside ahead?
The Nifty Pharma index has surged 14.53% YTD, outperforming the Nifty 50's 7.87% decline. Key drivers include improving earnings visibility and stable demand in domestic formulations, while geopolitical tensions and inflation concerns weigh on broader market sentiment.
4 min read15 Jul 2026After a dull Q4, Glenmark Pharma needs a booster shot to grow
Investors are shifting their focus to core operational execution as the drugmaker looks past one-off licensing gains to drive its FY27 growth.
2 min read2 Jun 2026Multibagger healthcare stock retraces from near record high. Do you own?
Sakar Healthcare stock had touched a record high of ₹829.60 in the last trading session, while its 52-week low stands at ₹306, hit on 23 May last year. NSE data shows that 1.55 lakh shares of the healthcare firm were traded today.
2 min read21 May 2026Gland Pharma to Biocon: Pharma stocks rally up to 27% in a month: Can they shield portfolio from US-Iran war-led risks?
The Nifty Pharma index has surged nearly 11% over the past month, significantly outperforming the Nifty 50, which declined 3.6% during the same period. On a year-to-date (YTD) basis, the Nifty Pharma index has gained 9.4%, while the benchmark Nifty 50 has fallen by an equal margin.
3 min read21 May 2026Nationwide chemist strike on 20 May loses steam as key states withdraw support
A planned shutdown by 1.2 million chemists has been compromised after 12 states and union territories withdrew support following government assurances to review the 'unregulated' growth of e-pharmacies.
2 min read18 May 2026Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.